Navigation Links
Cell Implants May Help Those Who Suffer From Parkinson's

There is an improvement in the motor symptoms of patients who suffer from Parkinson disease as a result of cell implants from the human retina, according to a study conducted by the University of Alabama.// Most patients who suffer from the neurodegenerative disorder require the levodopa medication for bringing the symptoms under control. This is used for treating tremors and spasms. The levodopa medication may result in dyskinesias and motor fluctuations in the long run, and the dosage may have to be increased after a period of 5 years.

Levodopa can be produced from the retinal pigment epithelial cells of human beings which can be isolated from the eye tissue after postmortem, developed in culture, after which it can be implanted in the human brain. The cell implants have been performed upon patients who suffered from advanced stages of the Parkinson disease, after conducting experiments upon animals. Efficacy evaluations were performed by the researchers on the patients who received the implants.

After a period of 12 months, an improvement of 48% was seen, and even after two years had passed, the improvement remained sustained. There were also improvements noticed in motor fluctuations, the quality of life, and daily living. The implants do not produce any side effects. The Archives of Neurology published the study in its December 2005 issue. A much bigger study with regard to safety and efficacy of the retina cell implant treatment has commenced, according to the research scientists.
'"/>




Page: 1

Related medicine news :

1. Breast Implants May Interfere With The Interpretation Of Mammogram Results
2. The Use Of Implants After Breast Cancer Questioned
3. Implants In The Ear Is Effective Against All Types Of Hearing Loss
4. Scientists Find Way To Stop Infection Of Implants
5. Early Cochlear Implants Prove To Be Effective
6. Uncontrolled Diabetes Spells Doom for Dental Implants
7. Silicone Implants Make No Significant Difference To Breast Cancer Survivors
8. Inner Ear Implants: Cure for Stammerers
9. Potentially Dangerous levels of Platinum Found in Women with Silicone Gel Breast Implants
10. Silicone Leaks Seen Among Women with Breast Implants
11. Earlier the Cochlear Implants Used Better the Speech
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... 2017 , ... Resoundant, Inc., the developer of Magnetic ... annual customer education symposium, a world-class learning conference that offers educational content designed ... 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations for ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of all holidays (IBT World Travel Trends Report). As travelers visit both urban ... range in temperatures, and prolonged sun exposure. In response, the outdoor industry has ...
(Date:3/28/2017)... ... ... Alert Sentry Group LLC., a leader in the Personal Emergency Response System industry, introduced ... Plus. These iSAFE products are the most affordable and most advanced medical alert systems ... direct GPS Location and two-way calling with the push of a button on a ...
(Date:3/28/2017)... ... , ... The Radiology Business Management Association (RBMA) is pleased to ... executive director. Mr. Still was selected through a careful months-long search by the RBMA ... known to our members, has been a part of building the RBMA since 1992,” ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology , a provider ... and attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and ... biometric face recognition to enable users to check in and out from anywhere ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 ... . This new business entity, Emosis Ltd, headquartered in ... and development of novel assays complementing the mother company existing technology ... support commercialization and sales development of Emosis kits. ... This strategic move starts building Emosis ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
Breaking Medicine Technology: